These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16468526)

  • 41. Initial antibiotic selection and patient outcomes: observations from the National Pneumonia Project.
    Bratzler DW; Ma A; Nsa W
    Clin Infect Dis; 2008 Dec; 47 Suppl 3():S193-201. PubMed ID: 18986289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial drug use in hospitalised paediatric patients: a cross-national comparison between Germany and Croatia.
    Ufer M; Radosević N; Vogt A; Palcevski G; Francetić I; Reinalter SC; Seyberth HW; Vlahović-Palcevski V
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):735-9. PubMed ID: 15880392
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Selection and use of anti-infective agents for intra-abdominal infections].
    Coelho JC; Baretta GA; Okawa L
    Arq Gastroenterol; 2007; 44(1):85-90. PubMed ID: 17639190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Current guidelines for the treatment of intra-abdominal infections].
    Esposito S; Carosi G; Leone S
    Infez Med; 2008 Feb; 16 Suppl 1():46-52. PubMed ID: 18382150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Principles and application protocols in the treatment of intra-abdominal infections].
    Concia E; Viscoli C
    Infez Med; 2008 Feb; 16 Suppl 1():57-62. PubMed ID: 18382152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective antimicrobial audit and feedback did not decrease case fatality: Experiences from a hospital in northern Taiwan.
    Cheng CY; Lee CY; Wu MW; Chang CH; Huang WY; Chuang YF; Tang PH; Cheng SH
    J Infect Dev Ctries; 2016 Apr; 10(4):395-9. PubMed ID: 27131002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical importance of early diagnosis of anaerobic non-clostridial infection].
    Svetukhin AM; Zemlianoĭ AB; Istratov VG; Blatun LA; Terekhova RP
    Khirurgiia (Mosk); 2005; (8):41-4. PubMed ID: 16091679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of current guidelines for intra-abdominal infections.
    Esposito S; Leone S; Carosi G
    J Chemother; 2009 Jul; 21 Suppl 1():30-5. PubMed ID: 19622448
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial management of intra-abdominal infections.
    Concia E; Viscoli C
    J Chemother; 2009 Jul; 21 Suppl 1():39-43. PubMed ID: 19622450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Endolymphatic antibiotic therapy of inflammatory infiltrates of the abdominal cavity].
    Ermolov AS; Udovskiĭ EE; Grigorian AR
    Sov Med; 1984; (12):34-6. PubMed ID: 6523230
    [No Abstract]   [Full Text] [Related]  

  • 51. [Interpretation of domestic and foreign guidelines on diagnosis and treatment of abdominal infection].
    Wu XW; Ren JA
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1023-1027. PubMed ID: 33212548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New guidelines for treatment of complicated intra-abdominal infections.
    Oldfield EC
    Rev Gastroenterol Disord; 2004; 4(4):213-5. PubMed ID: 15580156
    [No Abstract]   [Full Text] [Related]  

  • 53. Erratum to: "EPICO 3.0. Recommendations on invasive candidiasis in patients with complicated intra-abdominal infection and surgical patients with ICU extended stay" [Rev Iberoam Micol. 33 (4) (2016) 196-205].
    Maseda E; Rodríguez AH; Aguilar G; Pemán J; Zaragoza R; Ferrer R; Llinares P; Grau S;
    Rev Iberoam Micol; 2017; 34(1):61. PubMed ID: 28249671
    [No Abstract]   [Full Text] [Related]  

  • 54. The incremental cost of infections associated with multidrug-resistant organisms in the inpatient hospital setting-A national estimate.
    Johnston KJ; Thorpe KE; Jacob JT; Murphy DJ
    Health Serv Res; 2019 Aug; 54(4):782-792. PubMed ID: 30864179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost of care and antibiotic prescribing attitudes for community-acquired complicated intra-abdominal infections in Italy: a retrospective study.
    Dalfino L; Bruno F; Colizza S; Concia E; Novelli A; Rebecchi F; Spandonaro F; Alato C
    World J Emerg Surg; 2014; 9():39. PubMed ID: 25028594
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ampicillin/sulbactam: current status in severe bacterial infections.
    Rafailidis PI; Ioannidou EN; Falagas ME
    Drugs; 2007; 67(13):1829-49. PubMed ID: 17722953
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Does initial choice of antimicrobial therapy affect length of stay for patients with complicated intra-abdominal infections?
    Wilson SE; Turpin RS; Hu XH; Sullivan E; Mansley EC; Ma L
    Am Surg; 2005 Oct; 71(10):816-20. PubMed ID: 16468526
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infection.
    Carson JG; Turpin RS; Hu H; Ma L; Wilson SE
    Surg Infect (Larchmt); 2008 Feb; 9(1):15-21. PubMed ID: 18363464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
    Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Meta-analysis: ertapenem for complicated intra-abdominal infections.
    Falagas ME; Peppas G; Makris GC; Karageorgopoulos DE; Matthaiou DK
    Aliment Pharmacol Ther; 2008 May; 27(10):919-31. PubMed ID: 18266994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.